That’s it. $225 Million Raised by Atai (ATAI) Gets us Interested in the Psychedelics...

Redefining how the world approaches, prevents, and heals mental health disorders. LIVE QUOTE
psychedelic stock review

CBS News: Inside a Psychedelic Ketamine Therapy Sessions (Video).

Therapy Treatment Performed by Ehave's (EHVVF) Chief Medical Office Receive Rave Reviews and Offers Potential to Save Lives,

Why Isn’t Big Pharma Jumping Into Psychedelics (PsyTech).

Originally in PsyTech Jan 28, 2021. By Tessa Eskin Big Pharma is at a crossroads....

Latest article

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...

Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...

Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...